Filing Details
- Accession Number:
- 0001477449-24-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 16:09:32
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 16:09:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208500 | N Jason Gorevic | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-01 | 21,130 | $0.00 | 622,864 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 2,915 | $0.00 | 625,779 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 5,782 | $0.00 | 631,561 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 5,615 | $0.00 | 637,176 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 62,004 | $0.00 | 699,180 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 7,648 | $0.00 | 706,828 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-04 | 53,755 | $14.52 | 653,073 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Performance Stock Units | Acquisiton | 2024-03-01 | 63,393 | $0.00 | 63,393 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 21,130 | $0.00 | 21,130 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 2,915 | $0.00 | 2,915 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2024-03-01 | 5,782 | $0.00 | 5,782 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 5,615 | $0.00 | 5,615 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 62,004 | $0.00 | 62,004 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2024-03-01 | 7,648 | $0.00 | 7,648 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
63,393 | No | 4 | A | Direct | ||
42,263 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct | ||
22,460 | No | 4 | M | Direct | ||
124,008 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
- On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
- On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.